• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
United States Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
 

United States Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

on

  • 178 views

 

Statistics

Views

Total Views
178
Views on SlideShare
178
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    United States Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery United States Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery Document Transcript

    • United States Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 148Price: Single User License – US$2500United States Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and InsulinDeliverySummaryGlobalData’s new report, “United States Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the United States Diabetes CareDevices market. The report provides value (USD million), volume (units) and average price (USD)data for each segment and sub-segment within two market categories – Glucose Monitoring andInsulin Delivery. The report also provides company shares and distribution shares data for each ofthe aforementioned market categories. The report is supplemented with global corporate-levelprofiles of the key market participants with information on company financials and pipelineproducts, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the United States DiabetesCare Devicesmarket.- Key players covered include LifeScan, Inc., Medtronic, Inc., Bayer HealthCare AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company and others.
    • Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the United States DiabetesCare Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197481-united-states-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 81.2 List of Figures 92 Introduction 112.1 What is This Report About? 113 Diabetes Care Devices In United States 123.1 Diabetes Care Devices, Market Segmentation 123.2 Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 133.3 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2011 143.4 Diabetes Care Devices Market, United States, Category Contribution (%), 2011 153.5 Diabetes Care Devices, United States, Company Share (2010-2011) 224 Glucose Monitoring In United States 244.1 Glucose Monitoring, Market Segmentation 244.2 Glucose Monitoring Market, United States, Revenue Mix ($m), 2011 254.3 Glucose Monitoring Market, United States, Segment Contribution (%), 2011 264.4 Glucose Monitoring Overall Revenue, (2004-2018) 274.4.1 Blood Glucose Meters, Revenue (2004-2018) 314.5 Glucose Monitoring Overall Volume (2004-2018) 354.5.1 Blood Glucose Meters, Volume (2004-2018) 394.6 Glucose Monitoring Average Price (2004-2018) 434.7 Glucose Monitoring Distribution Share (2010-2011) 444.8 Glucose Monitoring, United States, Company Share (2010-2011) 455 Insulin Delivery In United States 475.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2011 48
    • 5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2011 495.3 Insulin Delivery Overall Revenue, (2004-2018) 505.3.1 Insulin Pens, Revenue (2004-2018) 545.3.2 Insulin Pumps, Revenue (2004-2018) 585.4 Insulin Delivery Overall Volume (2004-2018) 625.4.1 Insulin Pens, Volume (2004-2018) 665.4.2 Insulin Pumps, Volume (2004-2018) 705.5 Insulin Delivery Average Price (2004-2018) 735.6 Insulin Delivery Distribution Share (2010-2011) 745.7 Insulin Delivery, United States, Company Share (2010-2011) 756 Overview of Key Companies in United States Diabetes Care Devices Market 776.1 LifeScan, Inc. 776.1.1 Company Overview 776.1.2 Share in the United States Diabetes Care Devices Market 776.2 Medtronic, Inc. 786.2.1 Company Overview 786.2.2 Share in the United States Diabetes Care Devices Market 786.3 Bayer HealthCare AG 796.3.1 Company Overview 796.3.2 Share in the United States Diabetes Care Devices Market 796.4 F. Hoffmann-La Roche Ltd. 806.4.1 Company Overview 806.4.2 Share in the United States Diabetes Care Devices Market 806.5 Abbott Laboratories 816.5.1 Company Overview 816.5.2 Share in the United States Diabetes Care Devices Market 826.6 Becton, Dickinson and Company 836.6.1 Company Overview 836.6.2 Share in the United States Diabetes Care Devices Market 836.7 Eli Lilly and Company 846.7.1 Company Overview 846.8 Animas Corporation 846.8.1 Company Overview 846.9 Novo Nordisk A/S 846.9.1 Company Overview 846.10 Sanofi 856.10.1 Company Overview 856.11 Insulet Corporation 856.11.1 Company Overview 856.12 ARKRAY, Inc. 866.12.1 Company Overview 866.13 B. Braun Melsungen AG 86
    • 6.13.1 Company Overview 867 Diabetes Care Devices Market Pipeline Products 878 Financial Deals Landscape 938.1 Acquisition 938.1.1 LifeScan Acquires Calibra Medical 938.1.2 Arriva Medical Acquires AmMed Direct For $23 Million 948.1.3 ActiveCare To Acquire 4G Biometrics, Healthcare Technology Company 958.1.4 DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To $8.5 Million 968.1.5 Arriva Medical Acquires Direct Diabetic Source 988.1.6 Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million 998.1.7 Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 1008.2 Partnerships 1018.2.1 Nextgen Healthcare Enters Into Technology Integration Agreement With Nipro Diagnostics1018.2.2 Alere Enters Into Co-Development Agreement With AT&T 1028.2.3 Telcare Enters Into Licensing Agreement With Diabetech For GlucoDynamix-ADMS 1038.2.4 Tethys Bioscience Enters Into Technology Integration Agreement With Lose It 1048.2.5 Juvenile Diabetes Research Foundation Extends Co-Development Agreement With Becton,Dickinson 1058.2.6 Juvenile Diabetes Research Foundation Enters Into Co-Development Agreement WithHelmsley Charitable Trust And Medtronic 1068.2.7 Tandem Diabetes Enters Into Licensing Agreement With DexCom 1078.2.8 Roche Diagnostics Enters Into Distribution Agreement With DexCom 1088.2.9 Roche Diagnostics Enters Into Research And Development Agreement With DexCom 1098.2.10 Pal Health Enters Into Distribution Agreement With Surefit For Xtremityone 1109 Recent Developments 1119.1 Strategy And Business Planning 1119.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center 1119.1.2 Aug 09, 2012: Takeda Establishes Development Center In China 1129.1.3 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs 1129.1.4 May 22, 2012: Greatbatch To Establish New Global Headquarters 1139.1.5 Mar 21, 2012: HealthMed To Expand Portfolio Of Products Beyond Organ Transplantation1149.1.6 Feb 27, 2012: Greatbatch Announces Engagement To Advance Medical Device Strategy1149.1.7 Jan 26, 2012: Nipro Diagnostics Purchases New Building, Expands Fort LauderdaleOperations 1159.1.8 Jan 19, 2012: BD And Mercy/ROi Collaborate To Improve Quality Of Care And ReduceCosts 1159.1.9 Oct 19, 2011: Abbott To Separate Into Two Leading Companies In Diversified MedicalProducts And Research-Based Pharmaceuticals 1169.1.10 Oct 13, 2011: Unisense Establishes US Headquarter 118
    • 9.2 Research And Development 1199.2.1 Jul 17, 2012: Greatbatch To Establish R&D Centre In Singapore 1199.2.2 Mar 21, 2012: Index Ventures Launches New €150m Life Sciences Fund With InvestmentsFrom GSK And Janssen 1209.2.3 Jan 09, 2012: Bayer HealthCare To Share Lab Space With Start-Up Companies 1219.3 Legal and Regulatory 1229.3.1 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision 1229.3.2 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision InDispute With Takeda 1229.3.3 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification ForMedical Devices 1229.3.4 Mar 30, 2012: Medtronic Reaches Settlement Of Shareholder Class Action 1239.3.5 Dec 23, 2011: Glancy Binkow Announces Class Action Lawsuit Against Hospira 1239.3.6 Dec 13, 2011: Medtronic Reaches Settlement With US Department of Justice 1239.3.7 Nov 22, 2011: Izard Nobel Announces Class Action Lawsuit Against Hospira 1249.4 Government and Public Interest 1259.4.1 Jun 28, 2012: American Diabetes Association Applauds US Supreme Court Decision ToUphold Affordable Care Act 1259.4.2 Jun 15, 2012: American Diabetes Association Applauds Passage Of Connecticut House Bill5348 1259.4.3 Jun 15, 2012: American Diabetes Association Applauds Federal Funding For DiabetesResearch And Prevention 1269.4.4 Jun 15, 2012: OSA Is Associated With Diabetic Peripheral Neuropathy: Study 1279.4.5 May 23, 2012: Beta Cell Imaging Could Help Spot Diabetes Earlier: Vanderbilt University1289.4.6 Mar 13, 2012: Researchers Identify Optimal Threshold For HbA1c Test For Prediabetes 1299.4.7 Mar 01, 2012: Diabetes Research Institute Develops Revolutionary Oxygen-GeneratingBiomaterial To Enhance Islet Survival 1309.4.8 Feb 13, 2012: Blood From Periodontal Disease Can Be Used To Screen For Diabetes: NYUStudy 1319.4.9 Jan 20, 2012: Researchers At Brown University Develops Biochip To Measures Glucose InSaliva 1329.4.10 Jan 11, 2012: American Diabetes Association Applauds Revised US State DepartmentPolicy 1339.4.11 Jan 03, 2012: Maternal Liver Grafts More Tolerable For Children With Rare Disease: UCSF1339.4.12 Oct 14, 2011: MannKind To Present At 18th Annual Newsmakers In BioTech IndustryConference 1349.4.13 Sep 29, 2011: Research At UC Reveals Hormone Action That Could Lead To TreatmentsFor Type 2 Diabetes 1349.4.14 Sep 14, 2011: Medtronic Pledges Action In Advance of United Nations High Level MeetingOn Noncommunicable Diseases 135
    • 9.5 Product News 1369.5.1 Oct 28, 2011: ARKRAYs GLUCOCARD Vital And 01 Blood Glucose Meters Are Listed OnDoD Uniform Formulary 1369.5.2 Jun 29, 2010: Medtronic Announces STAR 3 Trial Results Confirming MiniMed ParadigmREAL-Time System Achieves Better Glucose Control Than Daily Insulin Injections In DiabeticPatients 1379.5.3 Jun 25, 2010: Medtronic Begins Enrollment In ASPIRE Pivotal Study Of MiniMed Paradigmx54 System 1389.5.4 Mar 17, 2010: Medtronic Announces FDA Approval Of MiniMed Paradigm REAL-Time RevelSystem 1389.5.5 Aug 05, 2009: Continuous Glucose Monitoring Benefits Even Well-Controlled Type 1Diabetics 1399.5.6 Jul 10, 2009: Medtronic Announces Voluntary Recall Of Paradigm Specific Lots Of Quick-SetInfusion Sets 1409.5.7 Jun 07, 2009: Medtronic Presents REAL Trend Study Results Of MiniMed Paradigm REAL-Time System At 69th Annual Scientific Sessions Of The ADA 1409.5.8 May 05, 2009: Bayer HealthCare Releases CONTOUR Meters In Two Bold New Colors, TheMidnight Blue And Orange Burst 14110 Appendix 14210.1 Definitions of Markets Covered in the Report 14310.1.1 Diabetes Care Devices 14310.2 Research Methodology 14510.3 Secondary Research 14510.4 Primary Research 14610.5 Models 14610.6 Forecasts 14710.7 Expert Panels 14710.8 GlobalData Consulting 14710.9 Currency Conversion 14710.10 Contact Us 14710.11 Disclaimer 1481.1 List of TablesTable 1: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-201813Table 2: Diabetes Care Devices Market, United States, Category Contribution (%), 2011 15Table 3: Diabetes Care Devices, United States, Cross-Segment Analysis, 2004-2018 17Table 4: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Historic,2004-2011 19Table 5: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Forecast,2011-2018 21Table 6: Diabetes Care Devices, United States, Company Share by Revenue ($m), USD
    • Constant, 2010-2011 23Table 7: Glucose Monitoring Market, United States, Segment Contribution (%), 2011 26Table 8: Glucose Monitoring, United States, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 28Table 9: Glucose Monitoring, United States, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 30Table 10: Blood Glucose Meters, United States, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 32Table 11: Blood Glucose Meters, United States, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 34Table 12: Glucose Monitoring, United States, Volume (Units) by Segment, Historic, 2004-2011 36Table 13: Glucose Monitoring, United States, Volume (Units) by Segment, Forecast, 2011-2018 38Table 14: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 40Table 15: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 42Table 16: Glucose Monitoring, United States, Average Price ($), Historic, 2004-2011 43Table 17: Glucose Monitoring, United States, Average Price ($), Forecast, 2011-2018 43Table 18: Glucose Monitoring, United States, Distribution Share by Revenue ($m), USD Constant,2010-2011 44Table 19: Glucose Monitoring, United States, Company Share by Revenue ($m), USD Constant,2010-2011 46Table 20: Insulin Delivery Market, United States, Segment Contribution (%), 2011 49Table 21: Insulin Delivery, United States, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 51Table 22: Insulin Delivery, United States, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 53Table 23: Insulin Pens, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 55Table 24: Insulin Pens, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 57Table 25: Insulin Pumps, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 59Table 26: Insulin Pumps, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 61Table 27: Insulin Delivery, United States, Volume (Units) by Segment, Historic, 2004-2011 63Table 28: Insulin Delivery, United States, Volume (Units) by Segment, Forecast, 2011-2018 65Table 29: Insulin Pens, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 67Table 30: Insulin Pens, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 69Table 31: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 71Table 32: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 72Table 33: Insulin Delivery, United States, Average Price ($), Historic, 2004-2011 73
    • Table 34: Insulin Delivery, United States, Average Price ($), Forecast, 2011-2018 73Table 35: Insulin Delivery, United States, Distribution Share by Revenue ($m), USD Constant,2010-2011 74Table 36: Insulin Delivery, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 76Table 37: Diabetes Care Devices Market Pipeline Products 87Table 38: LifeScan Acquires Calibra Medical 93Table 39: Arriva Medical Acquires AmMed Direct For $23 Million 94Table 40: ActiveCare To Acquire 4G Biometrics, Healthcare Technology Company 95Table 41: DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To $8.5 Million 96Table 42: Arriva Medical Acquires Direct Diabetic Source 98Table 43: Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million99Table 44: Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 100Table 45: Nextgen Healthcare Enters Into Technology Integration Agreement With NiproDiagnostics 101Table 46: Alere Enters Into Co-Development Agreement With AT&T 102Table 47: Telcare Enters Into Licensing Agreement With Diabetech For GlucoDynamix-ADMS 103Table 48: Tethys Bioscience Enters Into Technology Integration Agreement With Lose It 104Table 49: Juvenile Diabetes Research Foundation Extends Co-Development Agreement WithBecton, Dickinson 105Table 50: Juvenile Diabetes Research Foundation Enters Into Co-Development Agreement WithHelmsley Charitable Trust And Medtronic 106Table 51: Tandem Diabetes Enters Into Licensing Agreement With DexCom 107Table 52: Roche Diagnostics Enters Into Distribution Agreement With DexCom 108Table 53: Roche Diagnostics Enters Into Research And Development Agreement With DexCom109Table 54: Pal Health Enters Into Distribution Agreement With Surefit For Xtremityone 1101.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 12Figure 2: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 13Figure 3: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2011 14Figure 4: Diabetes Care Devices Market, United States, Category Contribution (%), 2011 15Figure 5: Diabetes Care Devices, United States, Cross-Segment Analysis, 2004-2018 16Figure 6: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Historic,2004-2011 18Figure 7: Diabetes Care Devices, United States, Overall Revenue ($m), USD Constant, Forecast,2011-2018 20Figure 8: Diabetes Care Devices, United States, Company Share (%), 2011 22Figure 9: Glucose Monitoring, Market Segmentation 24
    • Figure 10: Glucose Monitoring Market, United States, Revenue Mix ($m), 2011 25Figure 11: Glucose Monitoring Market, United States, Segment Contribution (%), 2011 26Figure 12: Glucose Monitoring, United States, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 27Figure 13: Glucose Monitoring, United States, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 29Figure 14: Blood Glucose Meters, United States, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 31Figure 15: Blood Glucose Meters, United States, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 33Figure 16: Glucose Monitoring, United States, Volume (Units) by Segment, Historic, 2004-2011 35Figure 17: Glucose Monitoring, United States, Volume (Units) by Segment, Forecast, 2011-201837Figure 18: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 39Figure 19: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Forecast,2011-2018 41Figure 20: Glucose Monitoring, United States, Company Share (%), 2011 45Figure 21: Insulin Delivery, Market Segmentation 47Figure 22: Insulin Delivery Market, United States, Revenue Mix ($m), 2011 48Figure 23: Insulin Delivery Market, United States, Segment Contribution (%), 2011 49Figure 24: Insulin Delivery, United States, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 50Figure 25: Insulin Delivery, United States, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 52Figure 26: Insulin Pens, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 54Figure 27: Insulin Pens, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 56Figure 28: Insulin Pumps, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 58Figure 29: Insulin Pumps, United States, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 60Figure 30: Insulin Delivery, United States, Volume (Units) by Segment, Historic, 2004-2011 62Figure 31: Insulin Delivery, United States, Volume (Units) by Segment, Forecast, 2011-2018 64Figure 32: Insulin Pens, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 66Figure 33: Insulin Pens, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 68Figure 34: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 70Figure 35: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2011-201872Figure 36: Insulin Delivery, United States, Company Share (%), 2011 75Figure 37: LifeScan, Inc., Company Share (%),United States Diabetes Care Devices Market, 2011
    • 77Figure 38: Medtronic, Inc., Company Share (%),United States Diabetes Care Devices Market,2011 78Figure 39: Bayer HealthCare AG, Company Share (%),United States Diabetes Care DevicesMarket, 2011 79Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%),United States Diabetes Care DevicesMarket, 2011 80Figure 41: Abbott Laboratories, Company Share (%),United States Diabetes Care Devices Market,2011 82Figure 42: Becton, Dickinson and Company, Company Share (%),United States Diabetes CareDevices Market, 2011 83Contact: sales@reportsandreports.com for more information.